Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 109Neoplasms 99Lung Neoplasms 60Colorectal Neoplasms 45Prostatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 39Pancreatic Neoplasms 33Melanoma 31Head and Neck Neoplasms 27Neoplastic Cells, Circulating 25Ovarian Neoplasms 24Uterine Cervical Neoplasms 20Sarcoma 19Multiple Myeloma 19Glioma 19Colonic Neoplasms 19Carcinoma, Hepatocellular 17Leukemia, Myeloid, Acute 16Neoplasm Metastasis 15Squamous Cell Carcinoma of Head and Neck 14Lymphoma 14Glioblastoma 14Esophageal Neoplasms 14Endometrial Neoplasms 14Leukemia 12Kidney Neoplasms 11Hematologic Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11Myelodysplastic Syndromes 10

Interventions

Valganciclovir 4Blood Specimen Collection 3Valacyclovir 2Polymerase Chain Reaction 2Ganciclovir 2Flow Cytometry 2Cell Count 2letermovir 1Therapeutics 1Stem Cell Transplantation 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Gene-Eden-VIR 1Foscarnet 1Antiviral Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Cytomegalovirus Infections × Blood Specimen Collection × Clear all
NCT04017962 2025-08-11

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
102 enrolled 13 charts

Cytomegalovirus Infections

NCT03806764 2023-06-01

CReSCT

Melbourne Health

Phase NA Unknown
370 enrolled
Other hematologic neoplasm

Cytomegalovirus Infections, Virus Diseases, Hematologic Neoplasms

NCT02600065 2023-02-16

GLIO-CMV-01

University of Erlangen-Nürnberg Medical School

Completed
350 enrolled

Cytomegalovirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡